Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

URMEEL HASMUKH PATEL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1013263110
CMS profile
534521
Location
SHENANDOAH, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$18,956.92

334 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $10,107.50 4
Food and Beverage $6,748.91 318
Travel and Lodging $1,583.56 9
Honoraria $360.00 1
Education $156.95 2

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Bayer Healthcare Pharmaceuticals Inc. $6,982.01 12
AstraZeneca Pharmaceuticals LP $3,859.92 25
Janssen Biotech, Inc. $1,843.83 11
Daiichi Sankyo Inc. $504.03 9
Amgen Inc. $412.34 22
Novartis Pharmaceuticals Corporation $403.71 21
PFIZER INC. $381.76 25
GlaxoSmithKline, LLC. $357.30 12
Astellas Pharma US Inc $331.50 18
Celgene Corporation $330.81 16
GENZYME CORPORATION $318.74 11
E.R. Squibb & Sons, L.L.C. $173.22 16
Lilly USA, LLC $170.14 8
Eisai Inc. $169.44 10
Myriad Genetic Laboratories, Inc. $168.85 5
Stemline Therapeutics Inc. $149.35 10
Regeneron Pharmaceuticals, Inc. $141.77 1
Gilead Sciences, Inc. $138.25 7
SOBI, INC $124.52 5
Regeneron Healthcare Solutions, Inc. $116.63 4
Genentech USA, Inc. $110.92 5
Mirati Therapeutics, Inc. $108.94 1
ABBVIE INC. $103.23 5
Takeda Pharmaceuticals U.S.A., Inc. $98.80 4
Merck Sharp & Dohme LLC $97.55 5
Emmaus Medical, Inc. $94.91 3
Pharmacyclics LLC, An AbbVie Company $90.16 3
Seagen Inc. $88.01 5
TAIHO ONCOLOGY, INC. $64.23 4
CTI BioPharma Corp. $63.56 3
ARRAY BIOPHARMA INC $62.26 4
AVEO Pharmaceuticals, Inc. $61.71 3
MorphoSys, US Inc. $59.90 3
Deciphera Pharmaceuticals Inc. $56.52 2
Blueprint Medicines Corporation $54.89 2
Puma Biotechnology, Inc. $54.73 3
Dendreon Pharmaceuticals LLC $53.92 2
PharmaEssentia USA Corporation $51.23 2
Adaptive Biotechnologies Corporation $43.42 2
BeiGene USA, Inc. $41.43 2
Alexion Pharmaceuticals, Inc. $39.30 2
Karyopharm Therapeutics Inc. $35.35 2
Sirtex Medical Inc $30.20 2
Rigel Pharmaceuticals, Inc. $29.49 1
Ipsen Biopharmaceuticals, Inc $27.51 2
Shield Therapeutics Inc $24.26 1
TerSera Therapeutics LLC $22.98 1
G1 Therapeutics, Inc. $22.28 1
Alnylam Pharmaceuticals Inc. $21.93 1
EMD Serono, Inc. $21.27 1
Verity Pharmaceuticals Inc. $21.02 1
Kyowa Kirin, Inc. $20.63 1
JAZZ PHARMACEUTICALS INC. $16.55 1
Sun Pharmaceutical Industries Inc. $15.47 1
Spectrum Pharmaceuticals Inc. $14.74 1
Kite Pharma, Inc. $14.48 1
Incyte Corporation $14.38 1
Pharming Healthcare, Inc. $13.83 1
ADC Therapeutics America, Inc. $12.81 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

334 matching records · $18,956.92 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 334 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 334.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $30.0712/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049471995 CMS
Deciphera Pharmaceuticals Inc. $32.2212/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261053720421 CMS
Astellas Pharma US Inc $22.9212/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261034766341 CMS
Ipsen Biopharmaceuticals, Inc $13.8812/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261045415431 CMS
Sun Pharmaceutical Industries Inc. $15.4712/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261053992285 CMS
E.R. Squibb & Sons, L.L.C. $13.5912/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015454603 CMS
Eisai Inc. $17.6512/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261023335905 CMS
Eisai Inc. $1.3012/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261023335907 CMS
PFIZER INC. $14.4012/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050623231 CMS
Eisai Inc. $18.5712/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261023335909 CMS
AstraZeneca Pharmaceuticals LP $30.6712/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015775995 CMS
Celgene Corporation $29.0112/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015454597 CMS
GENZYME CORPORATION $29.1512/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061089301 CMS
Regeneron Pharmaceuticals, Inc. $141.7712/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261000029473 CMS
EMD Serono, Inc. $21.2712/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261032379005 CMS
Gilead Sciences, Inc. $17.5812/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025909721 CMS
GlaxoSmithKline, LLC. $12.3112/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261000994487 CMS
PFIZER INC. $14.8712/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050631415 CMS
Daiichi Sankyo Inc. $360.0012/04/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006580277 CMS
AstraZeneca Pharmaceuticals LP $24.5212/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015995409 CMS
Regeneron Healthcare Solutions, Inc. $33.3112/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026999357577 CMS
Stemline Therapeutics Inc. $9.1111/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040041069 CMS
Janssen Biotech, Inc. $30.5011/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988430707 CMS
Genentech USA, Inc. $25.8211/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040587663 CMS
AstraZeneca Pharmaceuticals LP $2,497.5011/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261012101767 CMS
Sirtex Medical Inc $19.7211/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261032402765 CMS
Rigel Pharmaceuticals, Inc. $29.4911/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261033435299 CMS
Lilly USA, LLC $15.1711/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261032152631 CMS
PFIZER INC. $22.3311/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050520469 CMS
SOBI, INC $15.2911/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261038106321 CMS
AstraZeneca Pharmaceuticals LP $22.4011/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015845561 CMS
Celgene Corporation $13.0311/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015454591 CMS
Gilead Sciences, Inc. $22.7311/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025717041 CMS
GlaxoSmithKline, LLC. $121.8611/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261000993957 CMS
Lilly USA, LLC $18.3911/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261032287153 CMS
Astellas Pharma US Inc $15.5711/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261034648661 CMS
Shield Therapeutics Inc $24.2611/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261045845713 CMS
Novartis Pharmaceuticals Corporation $26.4311/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992765825 CMS
Astellas Pharma US Inc $15.3111/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261034638443 CMS
AstraZeneca Pharmaceuticals LP $211.6011/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011560821 CMS
AstraZeneca Pharmaceuticals LP $48.6411/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015824139 CMS
Amgen Inc. $23.3210/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020693155 CMS
AstraZeneca Pharmaceuticals LP $21.4310/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014658243 CMS
GlaxoSmithKline, LLC. $13.0010/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261000994473 CMS
Daiichi Sankyo Inc. $24.7010/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006516173 CMS
Blueprint Medicines Corporation $31.9110/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051260309 CMS
SOBI, INC $25.5210/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261038137861 CMS
Daiichi Sankyo Inc. $24.7710/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006514071 CMS
Novartis Pharmaceuticals Corporation $18.2010/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992765821 CMS
AstraZeneca Pharmaceuticals LP $15.7010/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015615215 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,989.58 78
PY2020 $1,635.84 91
PY2021 $3,616.69 189
PY2022 $4,947.32 249
PY2023 $18,956.92 334
PY2024 $20,409.47 292
PY2025 $13,641.48 247

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
URMEEL HASMUKH PATEL, NPI 1013263110. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1013263110.
APA 7
IndustryPayments. (2026). URMEEL HASMUKH PATEL, NPI 1013263110 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1013263110
Bluebook
URMEEL HASMUKH PATEL, NPI 1013263110, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1013263110.

Source: Centers for Medicare & Medicaid Services, Open Payments.